Filing Flows › Comparisons › CRBU vs DBVT
Caribou Biosciences vs DBV Technologies S.A.: CRBU and DBVT compared
Caribou Biosciences is the larger company: $1.6M of revenue in its latest quarter (Q3 2026) against $1.6M for DBV Technologies S.A. (Q3 2026). Caribou Biosciences is growing faster (-27% against -43% a year earlier).
Where the money goes: CRBU and DBVT
Caribou Biosciences (CRBU) · Q3 2026
Caribou Biosciences, Q3 2026: revenue $1.6M (-27% year over year), net loss $26.6M, operating cash flow −$22.5M. The chart follows the revenue to costs, profit and cash.
DBV Technologies S.A. (DBVT) · Q3 2026
DBV Technologies S.A., Q3 2026: revenue $1.6M (-43% year over year), net loss $64.5M, operating cash flow −$51.5M. The chart follows the revenue to costs, profit and cash.
| Caribou Biosciences (CRBU) | DBV Technologies S.A. (DBVT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.6M | $1.6M |
| Revenue growth, Y/Y | -27% | -43% |
| Operating margin | n/m | n/m |
| Net earnings | −$26.6M | −$64.5M |
| Operating cash flow | −$22.5M | −$51.5M |
Questions
Which is bigger, Caribou Biosciences or DBV Technologies S.A.?
Caribou Biosciences is the larger company: $1.6M of revenue in its latest quarter (Q3 2026) against $1.6M for DBV Technologies S.A. (Q3 2026).
Is Caribou Biosciences or DBV Technologies S.A. growing faster?
Caribou Biosciences is growing faster (-27% against -43% a year earlier).
More: Caribou Biosciences earnings · how Caribou Biosciences makes money · DBV Technologies S.A. earnings · how DBV Technologies S.A. makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Oct 28, 2026). Fiscal quarters can end on different dates. Not investment advice.